High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$11.0M
$11,016,289
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -16.8%
2026-03-05
$547,705
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -16.8%
|
2026-03-05 | $547,705 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -21.4%
2026-03-04
$1,087,950Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -21.4%
|
2026-03-04 | $1,087,950Large | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -30.4%
2026-03-04
$1,231,310Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -30.4%
|
2026-03-04 | $1,231,310Large | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -14.2%
2026-03-04
$664,256
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -14.2%
|
2026-03-04 | $664,256 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -56.3%
2026-03-03
$2,014,404Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -56.3%
|
2026-03-03 | $2,014,404Large | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -35.1%
2026-03-03
$2,159,538Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -35.1%
|
2026-03-03 | $2,159,538Large | S | Form 4 |
|
TEVA
M
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • Exec. VP, European Commercial
Other
2025-12-09
$255,037
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Exec. VP, European Commercial
Other
|
2025-12-09 | $255,037 | M | Form 4 |
|
TEVA
M
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • Exec. VP, European Commercial
Equity Compensation
2025-12-09
$0
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Exec. VP, European Commercial
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
|
TEVA
M
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • Exec. VP, European Commercial
Equity Compensation
2025-12-09
$0
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Exec. VP, European Commercial
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • Exec. VP, European Commercial
Discretionary SellΔOwn -70.5%
2025-12-09
$3,311,126Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Exec. VP, European Commercial
Discretionary SellΔOwn -70.5%
|
2025-12-09 | $3,311,126Large | S | Form 4 |
|
TEVA
M
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • Exec. VP, European Commercial
Other
2025-12-09
$1,869,505Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Exec. VP, European Commercial
Other
|
2025-12-09 | $1,869,505Large | M | Form 4 |